Inflammation and pancreatic cancer: Recent development with focusing on potential new drug targets

Generoso Uomo, Luigi Laghi, Raffaele Pezzilli

Research output: Contribution to journalArticle

Abstract

Chronic inflammation has been identified as a significant factor in the carcinogenesis of various tumors, including pancreatic cancer. Both hereditary and classical forms of chronic pancreatitis are associated with an increased risk of developing pancreatic cancer. Cytokines and other mediators of the inflammatory process together with an upregulation of pro-inflammatory pathways play a pivotal role in oncogenesis' stimulation, tumor growth and metastasis. The presence of a strong desmoplastic reaction within and around pancreatic cancer cells renders the proteolytic degradation of extracellular matrix components an essential process for tumor invasion and metastasis. Various classes of proteases produced by the pancreatic acinar cells are involved in these proteolytic events. The multiple link between inflammation and pancreatic cancer may represent the basis for a novel antineoplastic strategy. Cytokines, proteases, reactive-oxygen-species, cyclooxygenase-2, nuclear-factor-κB and perixosome proliferator-activated receptor-γ may be a new molecular targets useful for therapeutic purpose.

Original languageEnglish
Pages (from-to)351-357
Number of pages7
JournalAnti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry
Volume10
Issue number5
Publication statusPublished - Oct 2011

Fingerprint

Pancreatic Neoplasms
Inflammation
Pharmaceutical Preparations
Carcinogenesis
Peptide Hydrolases
Cytokines
Neoplasm Metastasis
Neoplasms
Acinar Cells
Chronic Pancreatitis
Cyclooxygenase 2
Antineoplastic Agents
Extracellular Matrix
Reactive Oxygen Species
Up-Regulation
Growth
Therapeutics

Keywords

  • Chronic
  • Cyclooxygenase-2
  • Cytokines
  • Gabexate mesilate
  • Nuclear-factor-kappab
  • Pancreatic neoplasms
  • Pancreatitis
  • Perixosome proliferator-activated receptor-gamma
  • Proteases
  • Reactive oxygen species
  • Stromal cells

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy
  • Pharmacology

Cite this

Inflammation and pancreatic cancer : Recent development with focusing on potential new drug targets. / Uomo, Generoso; Laghi, Luigi; Pezzilli, Raffaele.

In: Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry, Vol. 10, No. 5, 10.2011, p. 351-357.

Research output: Contribution to journalArticle

@article{ca978c48eb9e4708959a8b4367265f34,
title = "Inflammation and pancreatic cancer: Recent development with focusing on potential new drug targets",
abstract = "Chronic inflammation has been identified as a significant factor in the carcinogenesis of various tumors, including pancreatic cancer. Both hereditary and classical forms of chronic pancreatitis are associated with an increased risk of developing pancreatic cancer. Cytokines and other mediators of the inflammatory process together with an upregulation of pro-inflammatory pathways play a pivotal role in oncogenesis' stimulation, tumor growth and metastasis. The presence of a strong desmoplastic reaction within and around pancreatic cancer cells renders the proteolytic degradation of extracellular matrix components an essential process for tumor invasion and metastasis. Various classes of proteases produced by the pancreatic acinar cells are involved in these proteolytic events. The multiple link between inflammation and pancreatic cancer may represent the basis for a novel antineoplastic strategy. Cytokines, proteases, reactive-oxygen-species, cyclooxygenase-2, nuclear-factor-κB and perixosome proliferator-activated receptor-γ may be a new molecular targets useful for therapeutic purpose.",
keywords = "Chronic, Cyclooxygenase-2, Cytokines, Gabexate mesilate, Nuclear-factor-kappab, Pancreatic neoplasms, Pancreatitis, Perixosome proliferator-activated receptor-gamma, Proteases, Reactive oxygen species, Stromal cells",
author = "Generoso Uomo and Luigi Laghi and Raffaele Pezzilli",
year = "2011",
month = "10",
language = "English",
volume = "10",
pages = "351--357",
journal = "Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry",
issn = "1871-5230",
publisher = "Bentham Science Publishers B.V.",
number = "5",

}

TY - JOUR

T1 - Inflammation and pancreatic cancer

T2 - Recent development with focusing on potential new drug targets

AU - Uomo, Generoso

AU - Laghi, Luigi

AU - Pezzilli, Raffaele

PY - 2011/10

Y1 - 2011/10

N2 - Chronic inflammation has been identified as a significant factor in the carcinogenesis of various tumors, including pancreatic cancer. Both hereditary and classical forms of chronic pancreatitis are associated with an increased risk of developing pancreatic cancer. Cytokines and other mediators of the inflammatory process together with an upregulation of pro-inflammatory pathways play a pivotal role in oncogenesis' stimulation, tumor growth and metastasis. The presence of a strong desmoplastic reaction within and around pancreatic cancer cells renders the proteolytic degradation of extracellular matrix components an essential process for tumor invasion and metastasis. Various classes of proteases produced by the pancreatic acinar cells are involved in these proteolytic events. The multiple link between inflammation and pancreatic cancer may represent the basis for a novel antineoplastic strategy. Cytokines, proteases, reactive-oxygen-species, cyclooxygenase-2, nuclear-factor-κB and perixosome proliferator-activated receptor-γ may be a new molecular targets useful for therapeutic purpose.

AB - Chronic inflammation has been identified as a significant factor in the carcinogenesis of various tumors, including pancreatic cancer. Both hereditary and classical forms of chronic pancreatitis are associated with an increased risk of developing pancreatic cancer. Cytokines and other mediators of the inflammatory process together with an upregulation of pro-inflammatory pathways play a pivotal role in oncogenesis' stimulation, tumor growth and metastasis. The presence of a strong desmoplastic reaction within and around pancreatic cancer cells renders the proteolytic degradation of extracellular matrix components an essential process for tumor invasion and metastasis. Various classes of proteases produced by the pancreatic acinar cells are involved in these proteolytic events. The multiple link between inflammation and pancreatic cancer may represent the basis for a novel antineoplastic strategy. Cytokines, proteases, reactive-oxygen-species, cyclooxygenase-2, nuclear-factor-κB and perixosome proliferator-activated receptor-γ may be a new molecular targets useful for therapeutic purpose.

KW - Chronic

KW - Cyclooxygenase-2

KW - Cytokines

KW - Gabexate mesilate

KW - Nuclear-factor-kappab

KW - Pancreatic neoplasms

KW - Pancreatitis

KW - Perixosome proliferator-activated receptor-gamma

KW - Proteases

KW - Reactive oxygen species

KW - Stromal cells

UR - http://www.scopus.com/inward/record.url?scp=84858773974&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84858773974&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:84858773974

VL - 10

SP - 351

EP - 357

JO - Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry

JF - Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry

SN - 1871-5230

IS - 5

ER -